Betulinic Acid Protects From Bone Loss in Ovariectomized Mice and Suppresses RANKL-Associated Osteoclastogenesis by Inhibiting the MAPK and NFATc1 Pathways

Osteoporosis

(2019) Juliet E Compston et al.   LANCET

Impact of Periprosthetic Fibroblast-Like Cells on Osteoclastogenesis in Co-Culture with Peripheral Blood Mononuclear Cells Varies Depending on Culture System

(2019) Miriam I. Koehler et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Betulin and its derivatives as novel compounds with different pharmacological effects

(2019) Shayan Amiri et al.   BIOTECHNOLOGY ADVANCES

Protective Effect of Acteoside on Ovariectomy-Induced Bone Loss in Mice

(2019) Lingling Yang et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Fracture prediction, imaging and screening in osteoporosis

(2019) Nicholas R. Fuggle et al.   Nature Reviews Endocrinology

MicroRNA‐218‐5p relieves postmenopausal osteoporosis through promoting the osteoblast differentiation of bone marrow mesenchymal stem cells

(2019) Jianqiang Kou et al.   JOURNAL OF CELLULAR BIOCHEMISTRY

Epigenetic regulation of bone remodeling by natural compounds

(2019) Nishikant Raut et al.   PHARMACOLOGICAL RESEARCH

Hexane Fraction of Turbo brunneus Inhibits Intermediates of RANK-RANKL Signaling Pathway and Prevent Ovariectomy Induced Bone Loss

(2019) Sachin Chaugule et al.   Frontiers in Endocrinology

From Osteoclast Differentiation to Osteonecrosis of the Jaw: Molecular and Clinical Insights

(2019) Anesi et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Therapeutic applications of betulinic acid nanoformulations

(2018) Ankit Saneja et al.   Annals of the New York Academy of Sciences

The polymethoxy flavonoid sudachitin suppresses inflammatory bone destruction by directly inhibiting osteoclastogenesis due to reduced ROS production and MAPK activation in osteoclast precursors

(2018) Yoko Ohyama et al.   PLoS One

A Matrine Derivative M54 Suppresses Osteoclastogenesis and Prevents Ovariectomy-Induced Bone Loss by Targeting Ribosomal Protein S5

(2018) Zhi Xin et al.   Frontiers in Pharmacology

Roles of Mitogen-Activated Protein Kinases in Osteoclast Biology

(2018) Kyunghee Lee et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Osteoporosis treatment: recent developments and ongoing challenges

(2017) Sundeep Khosla et al.   Lancet Diabetes & Endocrinology

p38α MAPK regulates proliferation and differentiation of osteoclast progenitors and bone remodeling in an aging-dependent manner

(2017) Qian Cong et al.   Scientific Reports

Selective Regulation of MAPK Signaling Mediates RANKL-dependent Osteoclast Differentiation

(2016) Kyunghee Lee et al.   International Journal of Biological Sciences

Platycodin D Inhibits Osteoclastogenesis by Repressing the NFATc1 and MAPK Signaling Pathway

(2016) Jae Ho Choi et al.   JOURNAL OF CELLULAR BIOCHEMISTRY

Protective Effects of Green Tea Polyphenol Against Renal Injury Through ROS-Mediated JNK-MAPK Pathway in Lead Exposed Rats

(2016) Haidong Wang et al.   MOLECULES AND CELLS

Peroxiredoxin II Negatively Regulates Lipopolysaccharide-Induced Osteoclast Formation and Bone Loss via JNK and STAT3

(2015) Hyojung Park et al.   ANTIOXIDANTS & REDOX SIGNALING

Leonurine hydrochloride inhibits osteoclastogenesis and prevents osteoporosis associated with estrogen deficiency by inhibiting the NF-κB and PI3K/Akt signaling pathways

(2015) Feng-Lai Yuan et al.   BONE

Protective effects of resveratrol on postmenopausal osteoporosis: regulation of SIRT1-NF-κB signaling pathway

(2014) Jing Feng et al.   ACTA BIOCHIMICA ET BIOPHYSICA SINICA

Alternative pathways of osteoclastogenesis in inflammatory arthritis

(2014) Iannis E. Adamopoulos et al.   Nature Reviews Rheumatology

Advances in osteoclast biology reveal potential new drug targets and new roles for osteoclasts

(2013) Brendan F Boyce   JOURNAL OF BONE AND MINERAL RESEARCH

Nicotine Affects Bone Resorption and Suppresses the Expression of Cathepsin K, MMP-9 and Vacuolar-Type H+-ATPase d2 and Actin Organization in Osteoclasts

(2013) Hideki Tanaka et al.   PLoS One

New targets for intervention in the treatment of postmenopausal osteoporosis

(2011) E. Michael Lewiecki   Nature Reviews Rheumatology

The effects of estrogen receptors α- and β-specific agonists and antagonists on cell proliferation and energy metabolism in human bone cell line

(2010) D. Somjen et al.   JOURNAL OF CELLULAR BIOCHEMISTRY

The  -Isoform of p38 MAPK Specifically Regulates Arthritic Bone Loss

(2009) C. Bohm et al.   JOURNAL OF IMMUNOLOGY

GM-CSF Regulates Fusion of Mononuclear Osteoclasts into Bone-Resorbing Osteoclasts by Activating the Ras/ERK Pathway

(2009) M. S. Lee et al.   JOURNAL OF IMMUNOLOGY

NF-κB modulators in osteolytic bone diseases

(2008) Jiake Xu et al.   CYTOKINE & GROWTH FACTOR REVIEWS

Cathepsin K Activity-dependent Regulation of Osteoclast Actin Ring Formation and Bone Resorption

(2008) Susan R. Wilson et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Defective Osteoclastogenesis by IKKβ-null Precursors Is a Result of Receptor Activator of NF-κB Ligand (RANKL)-induced JNK-dependent Apoptosis and Impaired Differentiation

(2008) Jesse E. Otero et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

JNK/c-Jun Signaling Mediates an Anti-Apoptotic Effect of RANKL in Osteoclasts

(2008) Fumiyo Ikeda et al.   JOURNAL OF BONE AND MINERAL RESEARCH

The JNK-dependent CaMK pathway restrains the reversion of committed cells during osteoclast differentiation

(2008) E.-J. Chang et al.   JOURNAL OF CELL SCIENCE